These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 10353249)

  • 21. Cardiac Fas-Dependent and Mitochondria-Dependent Apoptotic Pathways in a Transgenic Mouse Model of Huntington's Disease.
    Wu BT; Chiang MC; Tasi CY; Kuo CH; Shyu WC; Kao CL; Huang CY; Lee SD
    Cardiovasc Toxicol; 2016 Apr; 16(2):111-21. PubMed ID: 25800750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion.
    White JK; Auerbach W; Duyao MP; Vonsattel JP; Gusella JF; Joyner AL; MacDonald ME
    Nat Genet; 1997 Dec; 17(4):404-10. PubMed ID: 9398841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
    Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
    Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P
    J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
    Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease.
    Yu ZX; Li SH; Evans J; Pillarisetti A; Li H; Li XJ
    J Neurosci; 2003 Mar; 23(6):2193-202. PubMed ID: 12657678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase inhibitors: a novel therapeutic approach to Huntington's disease (complex mechanism of neuronal death).
    Sadri-Vakili G; Cha JH
    Curr Alzheimer Res; 2006 Sep; 3(4):403-8. PubMed ID: 17017871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Huntington's disease: From molecular basis to therapeutic advances.
    Krobitsch S; Kazantsev AG
    Int J Biochem Cell Biol; 2011 Jan; 43(1):20-4. PubMed ID: 21056115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.
    Spires TL; Grote HE; Varshney NK; Cordery PM; van Dellen A; Blakemore C; Hannan AJ
    J Neurosci; 2004 Mar; 24(9):2270-6. PubMed ID: 14999077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease.
    van Dellen A; Grote HE; Hannan AJ
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1007-19. PubMed ID: 16445565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA.
    Wang YL; Liu W; Wada E; Murata M; Wada K; Kanazawa I
    Neurosci Res; 2005 Nov; 53(3):241-9. PubMed ID: 16095740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenic models of Huntington's disease.
    Sathasivam K; Hobbs C; Mangiarini L; Mahal A; Turmaine M; Doherty P; Davies SW; Bates GP
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):963-9. PubMed ID: 10434294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.
    Canals JM; Pineda JR; Torres-Peraza JF; Bosch M; Martín-Ibañez R; Muñoz MT; Mengod G; Ernfors P; Alberch J
    J Neurosci; 2004 Sep; 24(35):7727-39. PubMed ID: 15342740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Huntington disease: new insights on the role of huntingtin cleavage.
    Wellington CL; Leavitt BR; Hayden MR
    J Neural Transm Suppl; 2000; (58):1-17. PubMed ID: 11128600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice.
    Li H; Li SH; Cheng AL; Mangiarini L; Bates GP; Li XJ
    Hum Mol Genet; 1999 Jul; 8(7):1227-36. PubMed ID: 10369868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?
    Davies SW; Beardsall K; Turmaine M; DiFiglia M; Aronin N; Bates GP
    Lancet; 1998 Jan; 351(9096):131-3. PubMed ID: 9439509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Neurodegeneration in R6/2 Mice Carrying the Huntington's Disease Mutation with a Super-Expanded CAG Repeat, Despite Normal Lifespan.
    Kielar C; Morton AJ
    J Huntingtons Dis; 2018; 7(1):61-76. PubMed ID: 29480204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic rat model of Huntington's disease.
    von Hörsten S; Schmitt I; Nguyen HP; Holzmann C; Schmidt T; Walther T; Bader M; Pabst R; Kobbe P; Krotova J; Stiller D; Kask A; Vaarmann A; Rathke-Hartlieb S; Schulz JB; Grasshoff U; Bauer I; Vieira-Saecker AM; Paul M; Jones L; Lindenberg KS; Landwehrmeyer B; Bauer A; Li XJ; Riess O
    Hum Mol Genet; 2003 Mar; 12(6):617-24. PubMed ID: 12620967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The early cellular pathology of Huntington's disease.
    Li XJ
    Mol Neurobiol; 1999; 20(2-3):111-24. PubMed ID: 10966117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic models of Huntington's disease.
    Bates GP; Mangiarini L; Mahal A; Davies SW
    Hum Mol Genet; 1997; 6(10):1633-7. PubMed ID: 9300654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.